Has Michael Hoffer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $24,015 in general payments to Michael Hoffer, MD across 78 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Hoffer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Hoffer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Hoffer, MD

Otolaryngology · Miami, FLNPI 1821069626

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $16,278 of the $24,015 with a category attached, or 67.8%. 10 manufacturers reported payments, led by Medical Device Business Services, Inc. at 46.7% of the total. Reporting peaked in 2019 at $10,658 and has fallen 94.9% since, to $546 in 2025. Among otolaryngology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,015in general payments, 2019–2025

Across 78 payments — averaging $307.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medical Device Business Services, Inc.$11K
Johnson & Johnson$7K
Cochlear Americas$3K
Med-el Corporation$955
Grace Medical, Inc.$638
Advanced Bionics, LLC$443
plus $597 from 4 others

$7,795in research payments, 2019–2025

Across 5 payments — averaging $1558.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Cochlear Americas$8K

What the payments were for

Consulting fees$16,27868%
Travel & lodging$3,31014%
Food & beverage$4,42818%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medical Device Business Services, Inc.	22	$11,222
Johnson & Johnson	6	$7,404
Cochlear Americas	18	$2,757
Med-el Corporation	11	$955
Grace Medical, Inc.	4	$638
Advanced Bionics, LLC	8	$443
Stryker	5	$187
Iotamotion, Inc.	1	$176
Acclarent, Inc	2	$133
Oticon Medical, LLC	1	$101

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

MATRIXMIDFACE$16,385
MATRIXNEURO$16,385
NA$14,290
CMF INSTRUMENTS$9,240
MODULAR HAND SYSTEM$9,240
Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$2,247
Baha$2,086
OSIA OSI300 IMPLANT$1,951
Mi1250 SYNCHRONY 2 FLEXsoft$521
BCI 602 Kit$521
ADHEAR Professional Kit$398
Baha BI300 implant 4 mm$297
Cochlear Osia OSI200 Implant$297
Cochlear$270
iotaSOFT$176
HIRES ULTRA CI HIFOCUS MS ELECTRODE$152
ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM$113
PONTO BONE ANCHORED HEARING SYSTEM$101

How this compares

$24,015 in reported general payments places this provider in the 95th percentile of 586 otolaryngology providers in Florida.

See all otolaryngology providers in Florida →

Medicare billing

Part B allowed, 2024

$53,240

Medicare patients

241

Services billed

405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ofloxacin	64	$1,695
Fluocinolone Acetonide Oil	13	$692
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	19	$234
Fluticasone Propionate	12	$150
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid	14	$86

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Miami

Maria SuurnaMiami$189K
Agustin ArrietaMiami$95K
Francisco PernasMiami$70K
Adrien EshraghiMiami$41K
Corinna LevineMiami$16K
Jason LeibowitzMiami$13K
Donald WeedMiami$8K
Cecelia DamaskOrlando$707K
Ralph TufanoSarasota$469K
Franklin RimellFort Myers$314K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →